Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Payables: 2018-2024

Historic Payables for Neurogene (NGNE) over the last 4 years, with Dec 2024 value amounting to $1.3 million.

  • Neurogene's Payables fell 8.31% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 6.34%. This contributed to the annual value of $1.3 million for FY2024, which is 48.54% down from last year.
  • Neurogene's Payables amounted to $1.3 million in FY2024, which was down 48.54% from $2.6 million recorded in FY2023.
  • Neurogene's 5-year Payables high stood at $2.6 million for FY2023, and its period low was $1.3 million during FY2024.
  • Its 2-year average for Payables is $2.0 million, with a median of $2.0 million in 2023.
  • Data for Neurogene's Payables shows a maximum YoY crashed of 48.54% (in 2024) over the last 5 years.
  • Over the past 2 years, Neurogene's Payables (Yearly) stood at $2.6 million in 2023, then crashed by 48.54% to $1.3 million in 2024.